Delivery Order SPE2DB20D1100-SPE2DB24FC9E3
Award Date 7/25/24
Potential Completion Date 8/15/24
Potential Value $1.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $1,216.11 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of Envarsus XR 1 mg tablets. This order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this IDC, AmerisourceBergen provides a wide range of pharmaceutical products and medical supplies to support the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,687.28 firm fixed-price contract is for the delivery of Envarsus XR 4 mg tablets, a transplant medication, to support military and federal healthcare programs. The contract has an ultimate completion date of August 21, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a delivery order award worth $6,461.32 to AmerisourceBergen Drug Corporation's Corporate Office Division by the Defense Logistics Agency (DLA). The order is for the pharmaceutical product Envarsus XR 4 mg tablet, which is a critical medical supply. The contract has a completion date of September 27, 2024 and is a firm fixed-price contract. AmerisourceBergen is a major supplier of pharmaceuticals and medical supplies to the federal government, particularly the Department of Defense and...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $1,216.11, is for the supply of Envarsus XR 1 mg tablets, a specialty brand name pharmaceutical medication. This delivery order falls under a larger indefinite delivery contract (IDC) between DLA and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,148.10, is for the provision of Envarsus XR 1 mg tablets, a pharmaceutical product. The contract is a Firm Fixed Price (FFP) type and has an ultimate completion date of April 10, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The order, valued at $1,615.33, is for the supply of the specialty medication Envarsus XR 4 mg tablet 100s. The delivery order has an ultimate completion date of April 8, 2024 and is not associated with any set-aside designations. Amerisourcebergen Drug Corp serves as a prime...
- This federal contract award, valued at $1,621.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, for the delivery of Envarsus XR 1 mg tablets. The contract is a firm fixed price delivery order with an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Envarsus XR 1 mg tablets, a pharmaceutical product. The contract has a ceiling value of $1,288.86 and a performance period extending through May 28, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Envarsus XR 1 mg tablets. The contract has a ceiling value of $1,621.48 and a performance period through August 13, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies for the provision of a broad range of pharmaceutical and medical products to support military...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution company. The $1,621.48 order is for the supply of the pharmaceutical product Envarsus XR 1 mg Tablet 100s. The order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceuticals...